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Background. Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disorder leading to end-stage
renal failure. The objective of this study was to evaluate a longitudinal experience of kidney transplantation for ADPKD. Methods.
A single center retrospective review of patients undergoing kidney transplantation was conducted, with comparisons across two
time periods: early (02/2000–04/2007, 𝑛=6 6 ) and late (04/2007–08/2012, 𝑛=6 7 ). Results. Over the 13.5-year study period, 133
patients underwent transplantation for ADPKD. Overall, no significant difference between the early and late group with regard to
intraoperative complications, need for reoperation, readmissions within 30 days, delayed graft function, and mortality was noted.
There was a trend towards increase in one-year graft survival (early 93.1% versus late 100%, 𝑃 = 0.05). In the early group, 67% of
recipientshadundergoneaneurysmscreening,comparedto91%ofrecipientsinthelategroup(𝑃 < 0.001).Conclusions.Thisstudy
demonstrates consistent clinical care with a trend towards improved rates of one-year graft survival. Interestingly, we also note a
significantly higher use of cerebral imaging over time, with the majority that were detected requiring surgical intervention which
may justify the current practice of nonselective radiological screening until improved screening criteria are developed.
1. Introduction
Autosomaldominantpolycystickidneydisease(ADPKD)isa
disorder characterized by the development of renal cysts that
may result in end-stage renal failure. Two main genes, PKD1
and PKD2,a r etho ugh tt obein v o l v edinthema jo ri tyo fcases
[1]. Variability in the genetic phenotype of ADPKD patients,
h o w ev er ,i sth o ugh tt obed uet oth era n g eo fdiff er en tg en etic
mechanisms as well as environmental factors thought to play
aroleinphenotypicexpression[1].Inadditiontoaffectingthe
kidneys, ADPKD has a number of extrarenal manifestations
including cystic formation in other organs such as the liver,
seminal vesicles, pancreas, and arachnoid membrane; vascu-
lar malformations such as intracranial aneurysms, thoracic
aorta dissections, and coronary artery aneurysms; cardiac
manifestations such as mitral valve prolapse; and a higher
incidence of colonic diverticulosis and diverticulitis [1].
In those with end-stage renal disease, it is accepted that
transplantation is the preferred treatment for ADPKD [1].
Of the patients on the kidney transplant waiting list as of
December 31 2011, 7256 (8.4%) were listed due to cystic
kidney disease and of the 16,055 renal transplants performed
in 2011, 2057 (12.8%) were done for patients with cystic
kidneydisease,with1,189fromdeceaseddonorsand868from
living donors [2]. In patients undergoing transplantation
for ADPKD, current reports in the literature debate the
timing and need for native nephrectomy [3–14]a sw e l l
as the operative approach for native nephrectomy [14–17].
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Additionally, due to the potential for catastrophic outcomes
perioperatively of undiagnosed cerebral aneurysms, screen-
ing for their presence has been suggested at least among
subgroups of ADPKD patients [18]. However, there is no
clear consensus on management regarding need, timing, or
approach to nephrectomy as well as for screening for cerebral
aneurysms before undergoing kidney transplantation but
rather decisions appear to be patient specific and vary as a
function of time and center/surgeon preference. Given this,
the objective of this report was to study the longitudinal
experience of ADPKD and kidney transplantation at a single
center in order to (1) define overall outcomes with manage-
ment of this disease and (2) identify changes in practice and
outcomes over time.
2. Methods
A single center retrospective review of consecutive ADPKD
patientsundergoingtransplantsfrom02/2000to08/2012was
conducted. Data collected included recipient demographics,
donor type, timing of native nephrectomy if performed
(prior,simultaneous,or after transplant),reasonfor nephrec-
tomy, approach to nephrectomy (laparoscopic versus open),
lateralityofnephrectomy(unilateralorbilateral),totalopera-
tivetimeandestimatedbloodlossatthetimeofnephrectomy
and transplant, use of ureteral stents, weight of nephrectomy
kidney(s), need for intraoperative or postoperative trans-
fusion, intraoperative complications, need for reoperation,
need for readmission, delayed graft function, graft failure,
and death. Of note, delayed graft function was defined as the
need for dialysis within the first seven days after transplant.
The censor date for graft failure and death was January 1,
2013. In addition to these variables, data collected included
screeningforintracranialaneurysmsviaCT orMR andform
oftreatmentforthosefoundtohavebrainaneurysmsneeding
treatment.Ifavailable,familyhistoryforbrainaneurysmswas
also noted.
In order to assess changes in practice over time, patients
were chronologically ordered and divided into two nearly
equal groups based on transplant date: (1) early 02/2000–
04/2007) and (2) late (04/2007–08/2012). For the purposes
of data analysis, for the patients receiving more than one
transplant at our institution, each transplant event was
countedasaseparatecasesothatoutcomescouldbeanalyzed
independently. Univariate analysis was performed to look
for differences between groups. The independent samples
t-test was used for continuous variables and Pearson’s chi-
squareorFisher’sexacttestwasusedforcategoricalvariables.
Data analysis was performed using IBM Statistical Products
and Service Solutions (SPSS, Inc., Chicago Ill) version 21.0
for Windows. The Institutional Review Board of Partners
Healthcare approved this study.
3. Results
In the 13.5-year study period, data from 133 ADPKD patients
who underwent kidney transplantation was collected. Aver-
age overall age was 54.1 ± 10.3 years with 37.6% of patients
being female. The average number of months of dialysis
before transplant was 18.6 ± 21. The majority of transplants
were from deceased donors (45.1%), followed by living
unrelated donors (34.6%) and living related donors (20.3%).
Extendedcriteriadonorswereusedinninetransplants(6.8%)
and donation after cardiac death in 23 transplants (17.3%).
All nonheart beating donors were considered controlled. Of
the 133 ADPKD patients transplanted, six received a second
k i d n e yt r a n s p l a n t .Th r e eo ft h es i xh a dt h e i rfi r s tt r a n s p l a n t
done at an outside institution. Overall, the average number
of days in the hospital after transplant was 5.6 ± 3.5 days.
Indications for pretransplant, simultaneous, and post-
transplant nephrectomy are listed in Table 1.S o m ep a t i e n t s
had more than one indication for nephrectomy. Overall,
92 patients (69.2%) received a nephrectomy, some patients
receivingmorethanone.Withregardtotiming,eightpatients
(6%) underwent pretransplant native nephrectomy with 7
of these (87.5%) being unilateral. Simultaneous nephrectomy
was performed in 74 patients (55.6%) with 67 of these
(90.5%) being unilateral. All pretransplant and simultaneous
nephrectomies were performed using an open technique.
Lastly, 25 patients (18.8%) underwent posttransplant native
n e p h r e c t o m yw i t h1 4o ft h e s e( 5 6 % )b e i n gu n i l a t e r a la n d1 7
being laparoscopic (68%). Combined approaches were done
in four patients (3%) who underwent both a pretransplant
and simultaneous native nephrectomy and 11 patients (8.3%)
who underwent both a simultaneous and posttransplant
nephrectomy.
With regard to pretransplant cerebral aneurysm screen-
ing, of the 133 patients analyzed in this study, 105 (78.9%)
received radiologic imaging (CT or MR) to screen for brain
aneurysms.Ofthosescreened,12patients(12.4%)werefound
to have brain aneurysms with seven undergoing surgical
treatment with clipping. Data regarding the size of intracra-
nial aneurysms was available for 10 of the 12 cases, with
the average size being 3.75 ± 1.41mm in those undergoing
intervention. The location of intracranial aneurysms was
diverse and included the anterior communicating artery,
middle cerebral artery, posterior cerebral artery, paraclinoid
internal carotid artery, and basilar artery. Six patients were
found to have a positive family history for brain aneurysm,
butnoneofthesepatientswerefoundtohavebrainaneurysm
after undergoing radiological screening.
Results of a univariate analysis comparing the first 66
patientsinthisseries(theearlygroupspanningfrom02/2000
to 04/2007) to the subsequent 67 patients (the late group
spanningfrom04/2007to08/2012)arepresentinTables2and
3.Therewasnosignificantdifferenceinthedonorpopulation
utilized between the two eras (Table 2). Of note, significantly
more patients were screened for brain aneurysms in the
late group (91% versus 66.7%, 𝑃 = 0.001)a n da l t h o u g ha
higherpercentagewerefoundtohavebrainaneurysmsinthe
late group (14.8% versus 6.8%, 𝑃 = 0.207), the difference
was not statistically significant. With regard to operative
technique,ureteralstentsweresignificantlymorecommonin
the late group (64.2% versus 21.2%). Other notable findings
include significantly less simultaneous nephrectomies in
t h el a t eg r o u p( 2 2 . 4 %v e r s u s8 9 . 4 % ,𝑃 < 0.001)a n daJournal of Transplantation 3
Table 1: Indications and timing of nephrectomy.
Indication
Timing of nephrectomy
Pretransplant nephrectomy
(𝑛=8 )
Simultaneous nephrectomy
(𝑛=7 4 )
Posttransplant nephrectomy
(𝑛=2 5 )
Size 4 (50%) 55 (74.3%) 4 (16%)
Bleeding 2 (25%) 5 (6.8%) 4 (16%)
Subjective symptoms (e.g., early
satiety and chronic pain) 3 (37.5%) 4 (5.4%) 14 (56%)
Infection 0 0 4 (16%)
Hypertension 0 0 3 (12%)
Suspicion of neoplasia 0 0 1 (4%)
Hematuria 0 1 (1.4%) 2 (8%)
Not clearly specified 4 (50%) 11 (14.9%) 1 (4%)
Note: some patients had more than one indication for nephrectomy.
marginally significant higher proportion of posttransplant
nephrectomies (25.4% versus 12.1%, 𝑃 = 0.050). Of the
posttransplant nephrectomies, there were significantly less
unilateral (35.3% versus 100%, 𝑃 = 0.003) and open (5.9%
versus 87.5%, 𝑃 < 0.001) in the late group. The total operative
time at transplant was lower in the late group (212.9 minutes
±59.7 versus 265.0 minutes ±62.3, 𝑃 < 0.001). Lastly, there
wasnosignificantdifferencebetweentheearlyandlategroup
with regard to delayed graft function (12.1% versus 16.4%,
𝑃 = 0.479) and mortality (8.2% versus 15%, 𝑃 = 0.242);
however, there was a trend towards improved one-year graft
survival in the late group (93.1% versus 100%, 𝑃 = 0.05).
Intraoperative complications occurred in 6 patients
(4.5%). After transplant, 11 patients (8.3%) required reop-
eration. Overall, 24 (18%) of patients required readmission
within 30 days of discharge. Reasons for readmission are
demonstrated in Table 4. With regard to graft and patient
outcomes,19patients(14.3%)haddelayedgraftfunction.The
overallmeanfollow-upwas79.2±108.5months.Graftfailure
occurredin19patients(14.2%)andtheaveragetimetoknown
graft failure was 46.9 ± 41.7 months. Reasons for failure are
shown in Table 4. Death occurred in 14 patients (10.5%) and
the average time to death was 56.0 ± 44 months. Reasons for
death are shown in Table 4.
4. Discussion
Of the monogenic disorders, autosomal dominant polycystic
kidney disease is the most prevalent [1]. As ADPKD may
result in end-stage renal failure, transplantation is often
necessary for treatment of this disease. In the current series,
133patientsunderwenttransplantationforADPKDatasingle
centerover13.5years,with92(69.2%)ofthesepatientsreceiv-
ing nephrectomy for indications varying depending upon
time of nephrectomy. Over time, simultaneous nephrec-
tomy became less common and posttransplant laparoscopic
nephrectomybecamethemorefrequentprocedureofchoice.
With regard to preoperative workup, there was an increas-
ing frequency of screening for intracranial aneurysms in
ADPKD recipients. Intraoperative complications remained
infrequent; however, the need for readmissions persisted,
l i k e l yr e l a t e dt ot h ec o m p l e x i t yo fm a n a g i n gt h ep o s t t r a n s -
plant patient. The operative duration shortened in the late
time period, likely related to a decreased use of unilateral
concomitant native nephrectomy, and there was a trend
towards improved one-year graft survival more recently.
AdvancesinconservativemanagementofADPKDsymp-
toms with the use of pain medication, antibiotics, trans-
fusion, and antihypertensives [13]a sw e l la sm i n i m a l l y
invasive methods such as laparoscopic cyst decortication
[19] for symptomatic relief have impacted the indications
for nephrectomy in this disease [13]. Symptoms such as
pain, fullness, early satiety, cystic hemorrhage, hypertension,
nephrolithiasis, and urinary tract infections serve as relative
indications for nephrectomy. In a single center retrospec-
tive review of native nephrectomy in 157 kidney transplant
patients with ADPKD, Patel et al. noted that, overall, the
most common indication for the 20% of patients undergoing
native nephrectomy was urinary tract infection (45%), pain
(39%), tumor suspicion (10%), hematuria (3%), and space
(3%) [20]. The frequency of these indications was quite
different than those identified in the current study in which
sizewasthemostcommonindicationforpatientsundergoing
pretransplant and simultaneous nephrectomy, whereas sub-
jective symptoms such as early satiety and chronic pain were
themostcommonindicationforthoseundergoingposttrans-
plantnephrectomy .Furthermore,itshouldbementionedthat
in addition to size considerations, at our institution it was
common practice during the early period for surgeons to
do simultaneous unilateral nephrectomy in order to then
subsequently perform an ureteroureterostomy anastomosis
f o rt h et r a n s p l a n t e dk i d n e y .A ss u r g e o n sb e g a nt op e r f o r m
ureterocystostomy more commonly in the later period,
the overall proportion of simultaneous native nephrectomy
b e c a m el e s s ,l i k e l yi np a r tt ot h i sc h a n g ei np r a c t i c e .
In addition to changes in the timing and approach to
nephrectomy,differencesintheuseofpreoperativescreening
were noted between the early and late groups. Specifically,
in the early group 66.7% of recipients underwent screening
compared to 91% in the late groups (𝑃 < 0.001). There
was no significant difference, however, noted in the number
found to have brain aneurysms or the number treated for4 Journal of Transplantation
Table 2: Comparison of categorical variables among the early and late experience in patients receiving transplantation for adult polycystic
kidney disease.
Categorical variable Early (𝑛=6 6 )L a t e ( 𝑛=6 7 ) 𝑃 value
Deceased donor 33 (50%) 27 (40.3%) 0.261
Living related donor 14 (21.2%) 13 (19.4%) 0.795
Living unrelated donor 19 (28.8%) 27 (40.3%) 0.163
Donation after cardiac death 12 (18.2%) 11 (16.4%) 0.788
Extended criteria donor
∗ 4 (6.1%) 5 (7.5%) 1.000
% male 25 (37.9%) 25 (37.3%) 0.946
Previous native nephrectomy
∗ 4 (6.1%) 4 (6.0%) 1.000
Previous native nephrectomy was unilateral
∗ 4 (100%) 3 (75%) 1.000
Screened for brain aneurysms 44 (66.7%) 61 (91%) 0.001
Found to have brain aneurysms 3 (6.8%) 9 (14.8%) 0.207
Treated for brain aneurysms
∗ 3 (100%) 5 (55.6%) 0.491
Simultaneous native nephrectomy 59 (89.4%) 15 (22.4%) <0.001
Simultaneous native nephrectomy was unilateral
∗ 53 (89.8%) 14 (93.3%) 1.000
Simultaneous native nephrectomy was open 59 (100%) 15 (100%) 1.000
Intraop transfusion required 6 (9.1%) 13 (19.4%) 0.089
Side of transplant was on the right 44 (66.7%) 61 (92.4%) <0.001
Ureteral stent 14 (21.2%) 43 (64.2%) <0.001
Intraoperative complications
∗ 3 (4.5%) 7 (10.4%) 0.325
Postop transfusion required 23 (34.8%) 20 (29.9%) 0.538
Need for reoperation 5 (7.6%) 6 (9%) 0.773
Readmission within 30 days 13 (19.7%) 12 (17.9%) 0.792
Posttransplant native nephrectomy 8 (12.1%) 17 (25.4%) 0.050
Posttransplant nephrectomy was unilateral
∗ 8 (100%) 6 (35.3%) 0.003
Posttransplant nephrectomy was open
∗ 7 (87.5%) 1 (5.9%) <0.001
DGF dialysis required 8 (12.1%) 11 (16.4%) 0.479
1-year graft survival
∗ 54 (93.1%) 62 (100%) 0.052
Death 9 (15%) 5 (8.2%) 0.242
∗Fisher’s exact test used as ≥1 cell has expected count less than 5.
DGF: delayed graft function.
these aneurysms. There are currently no societal guidelines
or an established standard of practice to screen for cerebral
aneurysms in patients with ADPKD. ADPKD patients with
history of subarachnoid hemorrhage, two or more relatives
with intracranial aneurysms or rupture, those in high-risk
occupations, undergoing major elective surgery, or having a
“warning headache” or severe anxiety regarding the issue are
suggested to be screened [18]. Specific information regard-
ing screening prior to kidney transplantation is lacking.
In a review of presymptomatic screening with magnetic
resonance angiography in ADPKD patients, Irazabal et al.
f o u n dth a tm o s tu n ru p t u r edi n tr a c r a n i ala n e u ry s m sh a v eth e
growthandrupturerisksthatarenothigherthanunruptured
intracranial aneurysms found in the general population thus
suggesting selective screening [21]. Similarly, a report by
G i b b se ta l .d e s i g n e dt os t u d yt h er i s ko fg r o w t ha n dr u p t u r e
of intracranial aneurysms detected suggests that since most
aneurysms detected by such screening are small and have a
low risk for rupture, presymptomatic screening should not
be done in those without a family history of unruptured
intracranial aneurysms [22]. Of note, in the current series,
all six patients with a family history underwent screening
a n dn o n ew e r ef o u n dt oh a v eb r a i na n e u r y s m s .A l t h o u g h
there remains a low level of aneurysm detection overall,
the majority detected required surgical intervention which
may justify the current practice of nonselective radiological
assessment until improved screening criteria are developed
for patients preparing to undergo kidney transplantation.
With regard to outcomes, it should be noted that over
time there was a trend towards improved 1-year graft survival
of100%.Unfortunatelythisstudywasnotdesignedtoidentify
independent factors responsible for this observation, but it
is possible that some of the above noted changes in practice
over time may have contributed. Comparisons of outcomes
of ADPKD patients treated with transplantation to other
series in the literature are limited in the fact that previously
publishedseriesoftenprovideoutcomesofparticularcohorts
of patients (e.g., those receiving pretransplant nephrectomy
or those undergoing simultaneous nephrectomy and trans-
plantation) as opposed to outcomes for overall experiences.Journal of Transplantation 5
Table 3: Comparison of continuous variables among the early and late experience in patients receiving transplantation for adult polycystic
kidney disease.
Continuous variable Early (𝑛=6 6 )L a t e ( 𝑛=6 7 ) 𝑃 value
A g ea tt r a n s p l a n t( y e a r s ) 5 3 . 7± 9.2 54.3 ± 11.3 0.716
Months of dialysis prior to transplant 17.3 ± 18.2 29.2 ± 23.5 0.427
Days in hospital after transplant 6.0 ± 4.4 5.1 ± 2.3 0.158
BMI 25.8 ± 5.9 27.7 ± 4.8 0.076
Previous native nephrectomy total op time (min) 192.3 ± 59.1 in 3 cases 178.3 ± 37.9 in 3 cases 0.747
Previous native nephrectomy EBL (milliliters) 250 ± 70.7 in 2 cases 273.3 ± 46.2 in 3 cases 0.677
Total weight of nephrectomy kidney(s) (grams) 1536.1 ± 903 in 57 cases 3385.6 ± 2304.4 in 28 cases <0.001
Total op time at time of transplant (min) 265.0 ± 62.3 212.9 ± 59.7 <0.001
Intraop transfusion of RBCs (units) 1.25 ± 0.5 in 4 cases 1.86 ± 1.1 in 7 cases 0.320
Intraop transfusion of FFP (units) 2 ± 0i n2c a s e s 3 . 6± 1.5 in 5 cases 0.218
Intraop transfusion of platelets (units) 0 1.5 ± 0.7 in 2 cases N/A
EBL at time of transplant (milliliters) 332.4 ± 220.5 in 48 cases 257.7 ± 311.5 in 66 cases 0.158
Postop transfusion of RBCs (units) 3.5 ± 3.6 in 23 cases 2.3 ± 1.2 in 17 cases 0.191
Postop transfusion of FFP (units) 7.5 ± 6.4 in 2 cases 2.7 ± 1.2 in 6 cases 0.476
Postop transfusion of platelets (units) 7 ± 1.7 in 3 cases 1 in 1 case N/A
Posttransplant native nephrectomy total op time (min) 167.3 ± 53.9 in 8 cases 191.8 ± 47.1 in 17 cases 0.257
Posttransplant native nephrectomy total EBL (milliliters) 458.3 ± 488.3 in 6 cases 232.3 ± 3 1 1 . 5i n1 5c a s e s 0 . 2 1 7
BMI: body mass index; EBL: estimated blood loss; RBCs: red blood cells; FFP: fresh frozen plasma.
Table 4: Reasons for readmission within 30 days of discharge, graft failure, and death in transplant recipients.
Reasons for readmission (𝑛=2 4 )R e a s o n s f o r g r a ft f a i l u r e ( 𝑛=1 9
∗) Reasons for death (𝑛=1 4 )
Elevated serum creatinine and/or concern for acute rejection (13, 54.2%) Acute rejection (3) Infection (4, 28.6%)
Volume overload (2, 8.3%) Chronic rejection (3) Malignancy (3, 21.4%)
Nausea (2, 8.3%) Calcineurin toxicity (3) Cardiovascular (1, 7.1%)
Chylocele (1, 4.2%) Infection (3) Dementia (1, 7.1%)
Diarrhea (1, 4.2%) Cardiovascular (2) Unknown (5, 35.7%)
Peritoneal dialysis catheter removal (1, 4.2%) Hyperacute rejection (1)
Perforated duodenal ulcer (1, 4.2%) Thrombotic microangiopathy (1)
Bladder stone (1, 4.2%) Technical (1)
Wound infection (1, 4.2%) Malignancy (1)
Hypophosphatemia (1, 4.2%) Unknown (3)
∗Frequencies not calculated due to some patients having multiple reasons.
Furthermore, institutional practices vary greatly and given
that most reports are of single center retrospective experi-
ences, cross comparisons are difficult.
Thereareseverallimitationstothisstudythatareinherent
to its being a retrospective single center review. Firstly, this
study was limited to variables that were available in the
electronic medical records of the patients studied. As this
study evaluated changes in practice over time, it should
be noted that there was generally more electronic medical
information available for patients operated on more recently
but more longitudinal follow-up available for patients oper-
ated on more remotely, thus possibly introducing bias.
S e c o n d l y ,a l t h o u g ht h i si sal a r g es e r i e so fp a t i e n t so v e ra
significant time span, the number of patients available for
specific stringent statistical analysis was limited due to the
prevalence of disease. Therefore, the possibility of Type II
e r r o rs h o u l db ec o n s i d e r e di ns u b c o h o r ta n a l y s e so fs m a l l
sample sizes even though appropriate statistical tests were
applied. Thirdly, the observations noted in this study about
t h ec h a n g ei np r a c t i c ep a t t e r n so v e rt i m er e fl e c tt h o s eo fa
singleinstitutionthatisoftendependentontheresourcesand
infrastructure of that particular institution and that may not
be directly applicable to the management of this disease at
large. Relevant to the current analysis is the fact that it was
thepracticeofthisinstitutiontoroutinelyperformipsilateral
nephrectomyatthetimeoftransplanttopermitcreationofan
ureteroneocystostomy.Thismayhavecontributedtothehigh
fraction of patients having a nephrectomy with simultaneous
transplantation. Lastly, it should be noted that division of
groups into early and late was done based on splitting the6 Journal of Transplantation
sample in half rather than splitting the time period in half
in order to allow for more statistically even comparisons of
groups with regard to total number of patients.
5. Conclusions
End-stage renal disease caused by autosomal dominant
polycystic kidney disease can effectively be managed by
renal transplantation. As a component of therapy, native
nephrectomy may also be done but there exists a large
degree of variability with respect to timing and approach of
nephrectomy. As evidenced by this report, even within the
same institution, there has been significant change with an
increase in the number of posttransplant, bilateral laparo-
scopic nephrectomies being performed. Although intraop-
erative complications, need for reoperation, readmission
rates, and mortality did not significantly change over time,
there was a trend towards improved 1-year graft survival
more recently. We also note a significantly higher use of
cerebral imaging over time, with the majority that were
detected requiring surgical intervention. As mentioned, this
may justify the current practice of nonselective radiological
screening until improved screening criteria are developed.
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